GlaxoSmithKline LLC

Durham, NC ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
5,294Participants+21% vs. prior year
$12.6MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#8 of 85Manufacturing in NCBy participants

Overview

GlaxoSmithKline LLC sponsors a self-funded health plan that covered 5,294 participants in plan year 2025, up 21% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, long-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
5,294 · prior year 4,382
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
GlaxoSmithKline Retiree Medicare HRA Plan, plan 902 (5,294 participants); GlaxoSmithKline Flexible Compensation Plan, plan 901 (3,765 participants)
Broker compensation
$200K across insured contracts
MedicalLife insuranceDentalVisionLong-term disabilitySeveranceDeath benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Hartford Life and AccidentAccidental Death and Dismemberment, Life, Long-term disability23,977$16.6M$200K
Eyemed Vision Care on Behalf of Fidelity Security Life Insurance Co.Vision23,779$2.3M—
Aetna Life Insurance Co.Medical57$1.7M—
Metropolitan Life Insurance CompanyDental2,755$1.2M—
UnitedHealthcare Insurance CompanyMedical27$274K—
Ace American Insurance CompanyAccidental Death and Dismemberment, Busi11,884$70K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$12.6M/ year

Estimated prescription spend: 5,294 participants × $2,371 national average per member. Usually higher once dependents are counted.

$326K–$805K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$95K–$238K
Lower-cost therapeutic alternatives$139K–$291K
Generic pricing vs. actual cost$60K–$181K
PBM contract terms$31K–$94K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
GlaxoSmithKline LLC
Sponsor EIN
23-1099050
Plan numbers
902, 901
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 23-1099050 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
GlaxoSmithKline Cash Balance Pension Plan
Type
Pension plan
Participants
35,701

About this data

Source: GlaxoSmithKline LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with GlaxoSmithKline LLC.

Request a correction · Methodology